A statistical evaluation of dose expansion cohorts in phase I clinical trials.
about
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Embracing model-based designs for dose-finding trials.Statistical controversies in clinical research: building the bridge to phase II-efficacy estimation in dose-expansion cohorts.Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs.
P2860
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@ast
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@en
type
label
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@ast
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@en
prefLabel
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@ast
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@en
P2093
P2860
P356
P1476
A statistical evaluation of dose expansion cohorts in phase I clinical trials.
@en
P2093
Gregory P Kalemkerian
Jeremy M G Taylor
Jincheng Shen
Kent A Griffith
Matthew J Schipper
Philip S Boonstra
Stephanie Daignault
Theodore S Lawrence
Thomas M Braun
P2860
P356
10.1093/JNCI/DJU429
P407
P577
2015-02-20T00:00:00Z